63.37
Apogee Therapeutics Inc 주식(APGE)의 최신 뉴스
Apogee Therapeutics stock hits 52-week high at $67.66 By Investing.com - Investing.com India
Is Apogee Therapeutics Inc. stock recession proofWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com
How to track smart money flows in Apogee Therapeutics Inc.2025 Price Momentum & Daily Market Momentum Tracking - newser.com
How to use Fibonacci retracement on Apogee Therapeutics Inc.Market Activity Recap & Risk Controlled Stock Pick Alerts - newser.com
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsPortfolio Value Report & Expert Approved Momentum Ideas - newser.com
Published on: 2025-11-15 19:11:00 - newser.com
Assessing Apogee Therapeutics (APGE) Valuation After Recent Surge in Investor Interest - Yahoo Finance
Why Apogee Therapeutics (APGE) Is Up 19.7% After Strong APG333 Trial Data and Cash Infusion - Yahoo Finance
Can volume confirm reversal in Apogee Therapeutics Inc.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Is Apogee Therapeutics Inc a good long term investmentPrice Channel Trading & Learn the Basics of Investing in 5 Days - earlytimes.in
Insider Sell Alert: Jane Henderson Sells 2,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock - Investing.com Canada
Henderson Jane, CFO of Apogee Therapeutics, sells $130k in stock By Investing.com - Investing.com South Africa
[Form 4] Apogee Therapeutics, Inc. Insider Trading Activity - Stock Titan
Apogee Therapeutics CFO Sells 2,000 Shares - TradingView
CFO Henderson Sells 2,000 ($130K) Of Apogee Therapeutics Inc [APGE] - TradingView
APGE | Apogee Therapeutics Inc. SEC Filings - MarketWatch
Is Apogee Therapeutics Inc. stock positioned for digital transformation2025 Macro Impact & Daily Stock Momentum Reports - newser.com
Will Apogee Therapeutics Inc. stock remain a Wall Street favoriteWeekly Earnings Recap & Safe Capital Growth Tips - Fundação Cultural do Pará
Apogee Therapeutics’ APG777 Study: A Potential Breakthrough in Atopic Dermatitis Treatment - MSN
Real time scanner hits for Apogee Therapeutics Inc. explainedJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - newser.com
Apogee Therapeutics Insider Sold Shares Worth $1,260,236, According to a Recent SEC Filing - MarketScreener
Apogee Therapeutics CEO Henderson sells $1.26 million in stock By Investing.com - Investing.com Nigeria
Published on: 2025-11-13 23:54:39 - newser.com
CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Henderson, Apogee Therapeutics CFO, sells $60k in stock By Investing.com - Investing.com Canada
Apogee Therapeutics CEO Henderson sells $1.26 million in stock - Investing.com India
Apogee Therapeutics Executives Sell Shares - TradingView
CFO Henderson Sells 1,000 ($60K) Of Apogee Therapeutics Inc [APGE] - TradingView
CEO Henderson Sells 20,000 ($1.3M) Of Apogee Therapeutics Inc [APGE] - TradingView
CEO Henderson Files To Sell 100,000 Of Apogee Therapeutics Inc [APGE] - TradingView
Apogee Therapeutics Reports Q3 2025 Financial Progress - MSN
Published on: 2025-11-12 14:24:11 - newser.com
Apogee Therapeutics stock hits 52-week high at 61.19 USD By Investing.com - Investing.com Nigeria
Is Apogee Therapeutics Inc. (APGE) Outperforming Other Medical Stocks This Year? - sharewise.com
Apogee Therapeutics’ Stock Surge: Is It Time To Jump In? - timothysykes.com
Apogee Therapeutics stock hits 52-week high at 61.19 USD - Investing.com India
자본화:
|
볼륨(24시간):